An undisclosed strategic investor has just joined the fifth round of funding for US-based healthcare company Anulex Technologies.
Anulex, which makes medical devices to repair spinal discs, raised $18.3m of a planned series E round of at least $20m.
US-based venture capital firm Hatteras’s Late Stage VC Fund also joined the funding for the first time as a strategic investor, along with repeat VC investors Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.
Rich Lunsford, Anulex’s executive president since December 2008, said: "We are very enthused to have a new strategic investor join our world class investor group and we believe there may be opportunities to collaborate with each other in the future"
The company previously said it had raised $10.2m in last June’s series D, $20m in 2006’s C round, $14m in 2003 and $3.4m in 2002’s first stage of funding.